What Fertility Preservation Options Are Available for Cancer Patients Before Treatment Begins?

A cancer diagnosis brings many concerns, and for those of reproductive age, the potential impact on future fertility often weighs heavily on their minds. Cancer treatments like chemotherapy, radiation, and surgery can damage reproductive organs and reduce the ability to conceive naturally. Understanding fertility preservation options before treatment begins allows patients to make informed decisions about their reproductive future during an already overwhelming time.

Dr. Silvana Chedid and Dr. Claudio Grieco at Chedid Grieco have helped countless patients navigate fertility preservation decisions. With decades of combined experience in reproductive medicine and a commitment to personalized care, the team understands each patient’s situation requires thoughtful consideration of both their cancer treatment timeline and their family-building goals.

Why Fertility Preservation Should Be Discussed Early

Time is critical when it comes to fertility preservation. Many cancer treatment protocols need to begin quickly, but delaying treatment by a few weeks to preserve fertility is often medically acceptable. According to the American Cancer Society, your cancer care team should discuss any possible fertility problems before treatment starts, and these conversations should consider your preferences, religious beliefs, and the cost of available options.

The impact of cancer treatment on fertility varies depending on the type and dose of chemotherapy drugs, the radiation site and dosage, and the patient’s age at treatment. Younger patients generally have a better chance of maintaining fertility, but even they face risks. For women, fertility preservation saves or protects embryos, eggs, or ovarian tissue so they can be used to have children in the future. For men, preservation focuses on collecting and storing sperm before treatment damages reproductive function.

Embryo and Egg Freezing Options

Embryo cryopreservation is one of the most established fertility preservation methods. This process involves stimulating the ovaries with hormones to produce multiple eggs, retrieving those eggs through a minor procedure, fertilizing them with sperm in a laboratory setting, and then freezing the resulting embryos for future use. This method has the strongest effectiveness data, though success rates vary by clinic and individual patient factors.

Egg freezing, or oocyte cryopreservation, offers another viable option. This technique follows the same ovarian stimulation and egg retrieval process as embryo freezing, but the eggs are frozen unfertilized. This option appeals to patients who do not have a partner or who prefer not to create embryos at this stage. The American Society of Reproductive Medicine declared this procedure no longer experimental in 2012, and pregnancy rates using frozen eggs now approach those achieved with frozen embryos.

Both processes typically require about two weeks of ovarian stimulation followed by the egg retrieval procedure. Some patients may benefit from a second cycle if time permits, as retrieving more eggs increases the likelihood of future pregnancy success. Before beginning these procedures, patients should talk with their oncologist to ensure the timing is safe.

Ovarian Tissue Preservation and Male Options

For patients who cannot delay treatment even briefly, ovarian tissue cryopreservation provides an alternative. This procedure involves surgically removing and freezing ovarian cortex tissue, which contains thousands of immature eggs. The tissue can later be transplanted back into the patient’s body when she is ready to pursue pregnancy. This method has resulted in at least 130 live births worldwide and is no longer considered experimental.

Sperm cryopreservation offers a straightforward preservation method for male patients. The process involves collecting and freezing sperm samples before treatment begins. According to research in the National Institutes of Health database, the successful sperm cryopreservation rate reaches 94.5%. For patients unable to provide a sample, doctors can extract sperm directly from the testicles through testicular sperm extraction.

Additional Protective Strategies

Beyond cryopreservation methods, other strategies may help protect fertility during treatment. Ovarian suppression using medications aims to reduce ovarian activity during chemotherapy, theoretically protecting eggs from damage. While this approach shows promise, the evidence remains mixed, and these medications should complement rather than replace proven fertility preservation methods.

Ovarian transposition, a surgical procedure moving the ovaries away from the radiation field, may benefit patients receiving pelvic radiation. This technique positions the ovaries in a location less likely to receive radiation exposure, potentially preserving some fertility function. For hormone-sensitive cancers like some breast cancers, fertility physicians may use aromatase inhibitors during ovarian stimulation to keep estrogen levels lower while still allowing egg retrieval.

Work with Dr. Silvana Chedid and Dr. Claudio Grieco

Facing cancer while thinking about future fertility requires guidance and compassionate support. Dr. Silvana Chedid and Dr. Claudio Grieco bring together advanced reproductive technology and personalized care to help patients protect their fertility options. The practice coordinates closely with oncology teams to ensure fertility preservation procedures fit safely within cancer treatment timelines.With decades of combined experience in reproductive medicine, Dr. Chedid and Dr. Grieco understand every patient’s situation is unique. They take time to explain each preservation option, discuss realistic expectations, and develop a plan aligning with both your cancer treatment needs and your reproductive goals. Contact the practice to schedule a consultation and explore your fertility preservation options.